Maze Therapeutics, Inc.
MAZE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $197 | $29 | $100 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $5 | $6 |
| Total Curr. Assets | $202 | $34 | $106 |
| Property Plant & Equip (Net) | $30 | $35 | $41 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $8 | $1 | $1 |
| Total NC Assets | $39 | $37 | $44 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $241 | $72 | $150 |
| Liabilities | – | – | – |
| Payables | $2 | $2 | $2 |
| Short-Term Debt | $5 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $10 | $15 |
| Total Curr. Liab. | $21 | $16 | $21 |
| LT Debt | $22 | $45 | $28 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 |
| Total NC Liab. | $23 | $45 | $28 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $27 | $30 | $32 |
| Total Liabilities | $44 | $61 | $49 |
| Equity | – | – | – |
| Pref Stock | $508 | $384 | $384 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$358 | -$396 | -$295 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $47 | $22 | $13 |
| Total Equity | $197 | $10 | $101 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $241 | $72 | $150 |
| Net Debt | -$170 | $20 | -$68 |